AVANIR PHARMACEUTICALS INC's ticker is and the CUSIP is 05348P40. A total of 1 filers reported holding AVANIR PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 2.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $12,849,000 | -64.1% | 758,055 | -74.8% | 0.74% | -61.4% |
| Q3 2014 | $35,839,000 | -38.3% | 3,006,682 | -70.8% | 1.93% | -32.4% |
| Q2 2014 | $58,058,000 | +42.7% | 10,294,143 | -7.1% | 2.85% | +30.9% |
| Q1 2014 | $40,679,000 | +8.4% | 11,084,443 | -0.8% | 2.18% | +5.4% |
| Q4 2013 | $37,534,000 | -20.5% | 11,170,891 | +0.1% | 2.07% | -26.7% |
| Q3 2013 | $47,184,000 | -8.6% | 11,154,701 | -0.6% | 2.82% | -14.2% |
| Q2 2013 | $51,611,000 | – | 11,219,880 | – | 3.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 11,084,443 | $40,679,000 | 2.18% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 42,537 | $156,000 | 0.00% |